At the 2024 Asia Biotech Expo, MinoHealth showcased its latest diabetic foot risk management system. This innovative technology utilizes artificial intelligence and sensing technology to measure the risks for diabetic patients at an early stage.During the exhibition, MinoHealth engaged with leading global biotech companies and industry experts, promoting new developments in health technology. We are deeply grateful to all our esteemed partners who exchanged ideas with us during the event.
Through this exhibition, MinoHealth successfully attracted distribution partners and further expanded its market presence in the biotech field, committing to creating a better health management environment for diabetic patients.